The HH signaling pathway is essential for embryonic development and tissue homeostasis, but its aberrant activation, usually through mutations in PTCH1 or Smoothened (SMO) genes, plays a pivotal role in BCC pathogenesis. This evidence concerns the gene PTCH1 and skin basal cell carcinoma.